Skip to main content
KRMD logo

KRMD · KORU Medical Systems, Inc. · Executive Compensation

Track KRMD — free
$3.22 +0.05 (+1.58%) Q2 2026 earnings call transcript
Market Cap
$146.36M
Shares
46.17M
Volume · Oct 28 6262 Avg daily vol (3M) 240.26K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024
Executive Total
Linda Tharby $1,271,525
Brian Case $688,291
Thomas Adams $565,049
Kenneth Miller $543,255
Fiscal 2023
Executive Total
Linda Tharby $976,663
Kenneth Miller $697,424
Thomas Adams $572,954
Brian Case $460,144
Fiscal 2022
Executive Total
Brian Case $1,301,529
Linda Tharby $962,600
Thomas Adams $381,900
Kenneth Miller —
Fiscal 2021
Executive Total
Linda Tharby $7,052,291
Thomas Adams $602,560
Donald B. Pettigrew $351,923
James Beck $325,191
Karen Fisher $297,994
Manuel Marques $260,249
Brian Case —
Fiscal 2020
Executive Total
Donald B. Pettigrew $378,584
Karen Fisher $347,083
Manuel Marques $321,900
Fiscal 2019
Executive Total
Donald B. Pettigrew $1,804,635
Karen Fisher $903,229
Manuel Marques $656,517
Daniel S. Goldberger $445,362
Fiscal 2018
Executive Total
Donald B. Pettigrew $836,339
Daniel S. Goldberger $727,001
Karen Fisher $273,000

Executive changes

Person Change Filed
Adam Kalbermatten Appointed 2026-03-16
Adam Kalbermatten Appointed 2026-03-16
Adam Kalbermatten Appointed 2026-03-16
Linda Tharby Resigned 2026-03-16
Linda Tharby Retired 2026-03-16
Kenneth Miller Resigned 2025-04-07
Brian Case Terminated 2024-07-24
Ken Miller Appointed 2023-11-08
Kenneth Miller Appointed 2023-11-08
Edward Wholihan Appointed 2023-10-04
Thomas Adams Appointed 2023-08-02
Andrew D. C. LaFrence Resigned 2023-08-02
Andrew D. C. LaFrence Appointed 2023-06-27
Linda Tharby Appointed 2023-05-17
Shahriar (Shar) Matin Appointed 2023-05-17
Donna French Appointed 2023-05-17
Joseph M. Manko, Jr. Appointed 2023-05-17
Robert A. Cascella Appointed 2023-05-17
R. John Fletcher Appointed 2023-05-17

Leadership

Key facts CIK 704440 CUSIP 759910102 13F (30d) 6 filings 6 filers Visit website Investor relations